Elekta, Inc. recalls MOSAIQ Oncology Information System with Particle…
Elekta, Inc. recalls MOSAIQ Oncology Information System with Particle Therapy License (L…
- Published
- 21 Jan 2026
- Units affected
- 1
- Agency
- FDA
- Country
- United States
The hazard
Using oncology information system that manages workflow may result in overtreatment if:Plan delivered with Particle Therapy IHE-RO TDW-II interface,With one field per fraction or last field partial treatment,Partial treatment occurs followed by treatment field interruptions with manually recorded partial treatment,Then treatment unit doesn't check meterset value so partial treatment delivered twice
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Contact your doctor, clinic or the device maker to find out if your device is affected and what to do next. Do not stop using a life-supporting device without medical advice.
- Check the model and lot or serial number on the device label.
- Speak to your doctor or the clinic that supplied the device before stopping use.
Product details
MOSAIQ Oncology Information System with Particle Therapy License (License Kit 45700000000IQRO)
- Brand / company
- Elekta, Inc.
- Codes / lots
- MOSAIQ v 3.10.200, and 3.1.1.0 up to and including v 3.2.3.1 with Particle Base. Software Versions: 3.10.200, 3.1.1.0, 3.1.2.0, 3.1.3.0, 3.1.3.1, 3.1.3.2, 3.1.3.3, 3.1.3.4, 3.2.0.0, 3.2.1.0, 3.2.1.1, 3.2.1.2, 3.2.1.3, 3.2.1.4, 3.2.2.0, 3.2.2.1, 3.2.3.0, 3.2.3.1 UDI-DI: 07340201500026, 07340201500071
- Distribution
- US Nationwide distribution in the state of TX.
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 21 Jan 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.